Trademark: 97927507
Word
NEAAV
Status
Pending
Status Code
688
Status Date
Tuesday, May 7, 2024
Serial Number
97927507
Mark Type
4
Filing Date
Tuesday, May 9, 2023
Published for Opposition
Tuesday, March 12, 2024

Trademark Owner History
Asklepios BioPharmaceutical, Inc. - Owner At Publication

Classifications
5 Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; Therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; Biotechnological products, namely, viral DNA vectors, DNA vectors, and rAAV vectors, for the delivery of genes and other materials, in the nature of DNA, RNA, and transcriptional targeting promoters, to a biological cell for medical purposes; Biological preparations, namely, viral vectors, rAAV vectors, and DNA extracts for production of DNA vectors and viral vectors for medical purposes

Trademark Events
Feb 6, 2024
Priority Action Written
May 12, 2023
New Application Entered
Jun 7, 2023
New Application Office Supplied Data Entered
Feb 2, 2024
Assigned To Examiner
Feb 6, 2024
Priority Action E-Mailed
Feb 6, 2024
Notification Of Priority Action E-Mailed
Feb 7, 2024
Examiners Amendment -Written
Feb 7, 2024
Examiners Amendment E-Mailed
Feb 7, 2024
Notification Of Examiners Amendment E-Mailed
Feb 7, 2024
Examiner's Amendment Entered
Feb 7, 2024
Approved For Pub - Principal Register
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
May 7, 2024
Noa E-Mailed - Sou Required From Applicant
Mar 12, 2024
Published For Opposition
May 8, 2024
Teas Change Of Owner Address Received
May 8, 2024
Teas Change Of Correspondence Received
May 8, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
May 8, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 8, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered

Trademark Alertz updated from USPTO on 2030-01-24